Literature DB >> 16522264

Neurocognitive deficits in children with neurofibromatosis type 1.

Roger J Packer.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16522264     DOI： 10.1007/s11910-996-0033-8

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  6 in total

1.  Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation.

Authors:  D H Gutmann; A Loehr; Y Zhang; J Kim; M Henkemeyer; A Cashen
Journal:  Oncogene       Date:  1999-08-05       Impact factor: 9.867

2.  Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1.

Authors:  Rui M Costa; Nikolai B Federov; Jeff H Kogan; Geoffrey G Murphy; Joel Stern; Masuo Ohno; Raju Kucherlapati; Tyler Jacks; Alcino J Silva
Journal:  Nature       Date:  2002-01-16       Impact factor: 49.962

3.  Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.

Authors:  M B Denckla; K Hofman; M M Mazzocco; E Melhem; A L Reiss; R N Bryan; E L Harris; J Lee; C S Cox; L J Schuerholz
Journal:  Am J Med Genet       Date:  1996-02-16

4.  Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.

Authors:  T A Rizvi; S Akunuru; G de Courten-Myers; R C Switzer; M L Nordlund; N Ratner
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

5.  Cognitive function and academic performance in children with neurofibromatosis type 1.

Authors:  K North; P Joy; D Yuille; N Cocks; P Hutchins
Journal:  Dev Med Child Neurol       Date:  1995-05       Impact factor: 5.449

6.  Neuropsychological profile of children with neurofibromatosis, brain tumor, or both.

Authors:  B D Moore; J L Ater; M N Needle; J Slopis; D R Copeland
Journal:  J Child Neurol       Date:  1994-10       Impact factor: 1.987
  6 in total
  1 in total

1.  Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model.

Authors:  J L Lukkes; H P Drozd; S D Fitz; A I Molosh; D W Clapp; A Shekhar
Journal:  J Neurodev Disord       Date:  2020-01-15       Impact factor: 4.025
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.